Review The Situation Prestige Consumer Healthcare Inc. (PBH) Is In NowSeptember 12, 2019
Hopefully you got out of Prestige Consumer Healthcare Inc. (NYSE:PBH) early, as today the stock is trading 4.02% or 1.48 points down from last closing price of $36.8, reaching $35.32 at last check. The PBH share price has dropped in 1 of the last 5 days and is up 20.26% over the past week. It will be exciting to see whether the stock manages to continue decreasing or take a minor break for the next few days. The move came on weak volume too with far less shares changing hands than in a normal session. Trading activity as of this writing weakened by -169,521 shares, and in total 566079 shares valued at $19.994 million were seen changing hands compared with 735600 shares valued at $27.07 million recorded at the previous session. You should take into consideration that a falling volume on lower prices shows the bearish trend but this is an early indication which means that the PBH stock is near its bottom.
Prestige Consumer Healthcare Inc. (PBH) shares have notched a 3-month gain of about 20.26%, but has still advanced 19.17% year to date. By comparison, the stock sank -4.47% over the past 12 months, while it jumped 10.25% over the 1 month. The company’s market cap is around $1.9B, with its short interest ratio standing at 25.48%.
In the current trading session for PBH, the stock witnessed two major price actions, it rose to a high of $36.94 and was down as much as $35.29 at one point. The high recorded is very low when compared to their 52-week high which is $26.25. The 52-week high is now at -15.42 distance from current price. Their recent low of $41.76 represents a 34.55% recovery. This data is quite important for investors who look to benefit from the recent rise of the company’s stock. The price target currently for PBH is $34.67, this is below the recent high that the stock attained. Taking a look at the overall sentimental views of financial analysts, the trading pattern of this stock recently is very clear.
The stock of Prestige Consumer Healthcare Inc. earned $-0.71 per share in the trailing 12 months and has a P/E ratio of -49.75. You can compare it with that of similar companies in its industry to get a sense of whether the stock you’re looking to purchase is overvalued or undervalued. Its current price to earnings ratio is lower than the ones recorded by the industry which is 27.67 and lower compared to the sector’s average of 30.52. When the P/E ratio is low let’s say below 1.0, then the stock price is considered a good value. PBH also has P/S multiple of 1.91. This is greater versus the 12 month P/S ratios of other companies in the same indutry. The peer average price to sales ratio is 0.86x.
The company recorded an interesting insider sale transaction by the EVP on Nov 19, 2018. A Securities and Exchanges Commission filings show that Timothy Connors sold a total of 34,000 PBH shares that day for a sum of around $1,300,500. The filings show that the insider now retains 25,775 shares, currently worth…